These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 6313898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML, Robertson DW, Bloomquist WE, Wilson HC.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [Abstract] [Full Text] [Related]

  • 6. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ, Cohen ML.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [Abstract] [Full Text] [Related]

  • 7. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
    Docherty JR, Warnock P.
    J Cardiovasc Pharmacol; 1987 Jan; 10 Suppl 3():S59-61. PubMed ID: 2446073
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H, Chaouche-Teyara K, Cherqui C, Fournier B, Schmitt H.
    Arch Int Pharmacodyn Ther; 1990 Jan; 306():57-64. PubMed ID: 1981667
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
    Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):51-7. PubMed ID: 1731051
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
    Persson B, Gradin K, Pettersson A, Hedner T.
    J Cardiovasc Pharmacol; 1988 Jan; 11 Suppl 1():S22-4. PubMed ID: 2459509
    [Abstract] [Full Text] [Related]

  • 14. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
    Alper RH, Snider JM.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345
    [Abstract] [Full Text] [Related]

  • 15. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
    Cohen ML, Schenck KW, Colbert W, Wittenauer L.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826
    [Abstract] [Full Text] [Related]

  • 16. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
    Kalkman HO, Engel G, Hoyer D.
    J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT2) alpha 1-receptor antagonist.
    Schröder G, Beckmann R, Gerbling KP, Loge O, Maass B, Müller B, Seidelmann D, Schneider HH, Schulz BG, Stürzebecher CS.
    Arzneimittelforschung; 1988 Jun; 38(6):765-70. PubMed ID: 2902861
    [Abstract] [Full Text] [Related]

  • 18. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W, Li MW, Thakali K, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [Abstract] [Full Text] [Related]

  • 19. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR, Joos GF, Pauwels RA.
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [Abstract] [Full Text] [Related]

  • 20. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.
    Dabiré H.
    Therapie; 1991 Apr; 46(6):421-9. PubMed ID: 1819150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.